nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—Enalapril—Lisinopril—dilated cardiomyopathy	0.301	1	CrCrCtD
Captopril—ACE—dilated cardiomyopathy	0.225	1	CbGaD
Captopril—ACE—Lisinopril—dilated cardiomyopathy	0.162	0.546	CbGbCtD
Captopril—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0651	0.219	CbGbCtD
Captopril—SLC22A6—Furosemide—dilated cardiomyopathy	0.0216	0.0726	CbGbCtD
Captopril—ALB—Furosemide—dilated cardiomyopathy	0.0184	0.0618	CbGbCtD
Captopril—ABCB1—Lisinopril—dilated cardiomyopathy	0.016	0.0537	CbGbCtD
Captopril—ABCB1—Spironolactone—dilated cardiomyopathy	0.0141	0.0473	CbGbCtD
Captopril—F2—cardial valve—dilated cardiomyopathy	0.011	0.234	CbGeAlD
Captopril—REN—pulmonary artery—dilated cardiomyopathy	0.0064	0.136	CbGeAlD
Captopril—REN—sympathetic nervous system—dilated cardiomyopathy	0.00623	0.132	CbGeAlD
Captopril—Patent ductus arteriosus—Furosemide—dilated cardiomyopathy	0.00591	0.0874	CcSEcCtD
Captopril—Pemphigoid—Furosemide—dilated cardiomyopathy	0.00393	0.0581	CcSEcCtD
Captopril—ACE—pulmonary artery—dilated cardiomyopathy	0.00273	0.0578	CbGeAlD
Captopril—ACE—sympathetic nervous system—dilated cardiomyopathy	0.00265	0.0562	CbGeAlD
Captopril—Pulmonary eosinophilia—Lisinopril—dilated cardiomyopathy	0.00202	0.0299	CcSEcCtD
Captopril—Pemphigus—Lisinopril—dilated cardiomyopathy	0.00193	0.0285	CcSEcCtD
Captopril—LTA4H—cardiac ventricle—dilated cardiomyopathy	0.00173	0.0366	CbGeAlD
Captopril—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.00163	0.0241	CcSEcCtD
Captopril—LTA4H—myocardium—dilated cardiomyopathy	0.00162	0.0344	CbGeAlD
Captopril—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.00159	0.0235	CcSEcCtD
Captopril—MMP2—Enalapril—Lisinopril—dilated cardiomyopathy	0.00156	1	CbGdCrCtD
Captopril—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.00137	0.0203	CcSEcCtD
Captopril—Hypotensive—Furosemide—dilated cardiomyopathy	0.00135	0.02	CcSEcCtD
Captopril—REN—cardiac ventricle—dilated cardiomyopathy	0.00133	0.0282	CbGeAlD
Captopril—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00127	0.0188	CcSEcCtD
Captopril—REN—myocardium—dilated cardiomyopathy	0.00125	0.0265	CbGeAlD
Captopril—MMP2—cardiac ventricle—dilated cardiomyopathy	0.00122	0.0259	CbGeAlD
Captopril—MMP2—myocardium—dilated cardiomyopathy	0.00115	0.0244	CbGeAlD
Captopril—LTA4H—heart—dilated cardiomyopathy	0.00113	0.024	CbGeAlD
Captopril—Diabetic—Lisinopril—dilated cardiomyopathy	0.00111	0.0164	CcSEcCtD
Captopril—Anuria—Lisinopril—dilated cardiomyopathy	0.00106	0.0156	CcSEcCtD
Captopril—MMP9—myocardium—dilated cardiomyopathy	0.001	0.0212	CbGeAlD
Captopril—LTA4H—cardiac atrium—dilated cardiomyopathy	0.000969	0.0205	CbGeAlD
Captopril—Ulcer—Spironolactone—dilated cardiomyopathy	0.000957	0.0142	CcSEcCtD
Captopril—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.000936	0.0139	CcSEcCtD
Captopril—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000927	0.0137	CcSEcCtD
Captopril—Enalapril—ACE—dilated cardiomyopathy	0.000927	1	CrCbGaD
Captopril—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.000889	0.0132	CcSEcCtD
Captopril—REN—heart—dilated cardiomyopathy	0.000874	0.0185	CbGeAlD
Captopril—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00081	0.012	CcSEcCtD
Captopril—MMP2—heart—dilated cardiomyopathy	0.000804	0.017	CbGeAlD
Captopril—REN—cardiac atrium—dilated cardiomyopathy	0.000748	0.0158	CbGeAlD
Captopril—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.000729	0.0108	CcSEcCtD
Captopril—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.000711	0.0105	CcSEcCtD
Captopril—MMP9—heart—dilated cardiomyopathy	0.000699	0.0148	CbGeAlD
Captopril—MMP2—cardiac atrium—dilated cardiomyopathy	0.000687	0.0146	CbGeAlD
Captopril—Blister—Furosemide—dilated cardiomyopathy	0.000683	0.0101	CcSEcCtD
Captopril—Cholestasis—Furosemide—dilated cardiomyopathy	0.000648	0.00959	CcSEcCtD
Captopril—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000643	0.00951	CcSEcCtD
Captopril—Ataxia—Spironolactone—dilated cardiomyopathy	0.000618	0.00914	CcSEcCtD
Captopril—F2—heart—dilated cardiomyopathy	0.00061	0.0129	CbGeAlD
Captopril—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.000575	0.00851	CcSEcCtD
Captopril—ACE—cardiac ventricle—dilated cardiomyopathy	0.000567	0.012	CbGeAlD
Captopril—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000562	0.00832	CcSEcCtD
Captopril—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00056	0.00829	CcSEcCtD
Captopril—ACE—myocardium—dilated cardiomyopathy	0.000534	0.0113	CbGeAlD
Captopril—Drug interaction—Furosemide—dilated cardiomyopathy	0.000531	0.00785	CcSEcCtD
Captopril—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000523	0.00774	CcSEcCtD
Captopril—Vasculitis—Furosemide—dilated cardiomyopathy	0.000504	0.00746	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000502	0.00743	CcSEcCtD
Captopril—Renal failure—Spironolactone—dilated cardiomyopathy	0.000498	0.00736	CcSEcCtD
Captopril—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000472	0.00699	CcSEcCtD
Captopril—Urine output increased—Furosemide—dilated cardiomyopathy	0.000445	0.00659	CcSEcCtD
Captopril—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00043	0.00636	CcSEcCtD
Captopril—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00042	0.00622	CcSEcCtD
Captopril—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00042	0.00622	CcSEcCtD
Captopril—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000415	0.00613	CcSEcCtD
Captopril—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000411	0.00608	CcSEcCtD
Captopril—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000407	0.00602	CcSEcCtD
Captopril—Polyuria—Furosemide—dilated cardiomyopathy	0.000407	0.00602	CcSEcCtD
Captopril—Alopecia—Spironolactone—dilated cardiomyopathy	0.000402	0.00594	CcSEcCtD
Captopril—Oliguria—Lisinopril—dilated cardiomyopathy	0.000401	0.00593	CcSEcCtD
Captopril—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000398	0.00589	CcSEcCtD
Captopril—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000396	0.00586	CcSEcCtD
Captopril—ALB—heart—dilated cardiomyopathy	0.000389	0.00825	CbGeAlD
Captopril—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000379	0.0056	CcSEcCtD
Captopril—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000378	0.0056	CcSEcCtD
Captopril—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000374	0.00553	CcSEcCtD
Captopril—ACE—heart—dilated cardiomyopathy	0.000373	0.00789	CbGeAlD
Captopril—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000369	0.00546	CcSEcCtD
Captopril—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000367	0.00543	CcSEcCtD
Captopril—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000363	0.00537	CcSEcCtD
Captopril—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000359	0.00531	CcSEcCtD
Captopril—Malaise—Spironolactone—dilated cardiomyopathy	0.000357	0.00528	CcSEcCtD
Captopril—Discomfort—Spironolactone—dilated cardiomyopathy	0.000333	0.00492	CcSEcCtD
Captopril—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000326	0.00483	CcSEcCtD
Captopril—Confusional state—Spironolactone—dilated cardiomyopathy	0.000326	0.00482	CcSEcCtD
Captopril—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000323	0.00478	CcSEcCtD
Captopril—ACE—cardiac atrium—dilated cardiomyopathy	0.000319	0.00675	CbGeAlD
Captopril—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000316	0.00468	CcSEcCtD
Captopril—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000315	0.00466	CcSEcCtD
Captopril—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000308	0.00456	CcSEcCtD
Captopril—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000306	0.00452	CcSEcCtD
Captopril—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000305	0.00452	CcSEcCtD
Captopril—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000303	0.00448	CcSEcCtD
Captopril—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000297	0.00439	CcSEcCtD
Captopril—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00029	0.0043	CcSEcCtD
Captopril—Somnolence—Spironolactone—dilated cardiomyopathy	0.000287	0.00425	CcSEcCtD
Captopril—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000285	0.00422	CcSEcCtD
Captopril—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000282	0.00417	CcSEcCtD
Captopril—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000277	0.0041	CcSEcCtD
Captopril—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000274	0.00405	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000273	0.00404	CcSEcCtD
Captopril—Renal failure—Furosemide—dilated cardiomyopathy	0.000271	0.00401	CcSEcCtD
Captopril—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000269	0.00398	CcSEcCtD
Captopril—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000266	0.00394	CcSEcCtD
Captopril—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000257	0.0038	CcSEcCtD
Captopril—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000255	0.00378	CcSEcCtD
Captopril—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000255	0.00377	CcSEcCtD
Captopril—Ataxia—Lisinopril—dilated cardiomyopathy	0.000252	0.00373	CcSEcCtD
Captopril—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000245	0.00362	CcSEcCtD
Captopril—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000234	0.00346	CcSEcCtD
Captopril—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000229	0.00339	CcSEcCtD
Captopril—Pruritus—Spironolactone—dilated cardiomyopathy	0.000228	0.00338	CcSEcCtD
Captopril—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000228	0.00337	CcSEcCtD
Captopril—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000227	0.00336	CcSEcCtD
Captopril—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000226	0.00334	CcSEcCtD
Captopril—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000221	0.00327	CcSEcCtD
Captopril—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00022	0.00326	CcSEcCtD
Captopril—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000217	0.00321	CcSEcCtD
Captopril—Dizziness—Spironolactone—dilated cardiomyopathy	0.000213	0.00316	CcSEcCtD
Captopril—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000213	0.00316	CcSEcCtD
Captopril—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000212	0.00313	CcSEcCtD
Captopril—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000211	0.00312	CcSEcCtD
Captopril—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00021	0.0031	CcSEcCtD
Captopril—Vomiting—Spironolactone—dilated cardiomyopathy	0.000205	0.00304	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000205	0.00303	CcSEcCtD
Captopril—Rash—Spironolactone—dilated cardiomyopathy	0.000204	0.00301	CcSEcCtD
Captopril—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000203	0.00301	CcSEcCtD
Captopril—Renal failure—Lisinopril—dilated cardiomyopathy	0.000203	0.00301	CcSEcCtD
Captopril—Vision blurred—Furosemide—dilated cardiomyopathy	0.000203	0.003	CcSEcCtD
Captopril—Headache—Spironolactone—dilated cardiomyopathy	0.000202	0.00299	CcSEcCtD
Captopril—Jaundice—Lisinopril—dilated cardiomyopathy	0.000201	0.00298	CcSEcCtD
Captopril—Anaemia—Furosemide—dilated cardiomyopathy	0.000199	0.00294	CcSEcCtD
Captopril—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000193	0.00285	CcSEcCtD
Captopril—Nausea—Spironolactone—dilated cardiomyopathy	0.000192	0.00284	CcSEcCtD
Captopril—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000186	0.00275	CcSEcCtD
Captopril—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000185	0.00274	CcSEcCtD
Captopril—Hallucination—Lisinopril—dilated cardiomyopathy	0.000185	0.00273	CcSEcCtD
Captopril—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000184	0.00272	CcSEcCtD
Captopril—Dry mouth—Furosemide—dilated cardiomyopathy	0.000179	0.00265	CcSEcCtD
Captopril—Confusional state—Furosemide—dilated cardiomyopathy	0.000177	0.00262	CcSEcCtD
Captopril—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000176	0.0026	CcSEcCtD
Captopril—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000175	0.00259	CcSEcCtD
Captopril—Shock—Furosemide—dilated cardiomyopathy	0.000173	0.00256	CcSEcCtD
Captopril—Flushing—Lisinopril—dilated cardiomyopathy	0.000172	0.00255	CcSEcCtD
Captopril—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000172	0.00254	CcSEcCtD
Captopril—Anorexia—Furosemide—dilated cardiomyopathy	0.000167	0.00248	CcSEcCtD
Captopril—Hypotension—Furosemide—dilated cardiomyopathy	0.000164	0.00243	CcSEcCtD
Captopril—Alopecia—Lisinopril—dilated cardiomyopathy	0.000164	0.00243	CcSEcCtD
Captopril—Tension—Lisinopril—dilated cardiomyopathy	0.000158	0.00234	CcSEcCtD
Captopril—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000158	0.00234	CcSEcCtD
Captopril—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000158	0.00233	CcSEcCtD
Captopril—Nervousness—Lisinopril—dilated cardiomyopathy	0.000157	0.00232	CcSEcCtD
Captopril—Somnolence—Furosemide—dilated cardiomyopathy	0.000156	0.00231	CcSEcCtD
Captopril—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000153	0.00226	CcSEcCtD
Captopril—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000152	0.00225	CcSEcCtD
Captopril—Fatigue—Furosemide—dilated cardiomyopathy	0.000151	0.00224	CcSEcCtD
Captopril—Constipation—Furosemide—dilated cardiomyopathy	0.00015	0.00222	CcSEcCtD
Captopril—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00015	0.00222	CcSEcCtD
Captopril—Anaemia—Lisinopril—dilated cardiomyopathy	0.000149	0.00221	CcSEcCtD
Captopril—Angioedema—Lisinopril—dilated cardiomyopathy	0.000148	0.00218	CcSEcCtD
Captopril—Malaise—Lisinopril—dilated cardiomyopathy	0.000146	0.00215	CcSEcCtD
Captopril—Syncope—Lisinopril—dilated cardiomyopathy	0.000145	0.00214	CcSEcCtD
Captopril—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000145	0.00214	CcSEcCtD
Captopril—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000144	0.00213	CcSEcCtD
Captopril—Palpitations—Lisinopril—dilated cardiomyopathy	0.000143	0.00211	CcSEcCtD
Captopril—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000142	0.0021	CcSEcCtD
Captopril—Cough—Lisinopril—dilated cardiomyopathy	0.000141	0.00208	CcSEcCtD
Captopril—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000139	0.00205	CcSEcCtD
Captopril—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000139	0.00205	CcSEcCtD
Captopril—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000137	0.00203	CcSEcCtD
Captopril—Chest pain—Lisinopril—dilated cardiomyopathy	0.000137	0.00203	CcSEcCtD
Captopril—Myalgia—Lisinopril—dilated cardiomyopathy	0.000137	0.00203	CcSEcCtD
Captopril—Discomfort—Lisinopril—dilated cardiomyopathy	0.000136	0.00201	CcSEcCtD
Captopril—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000134	0.00199	CcSEcCtD
Captopril—Confusional state—Lisinopril—dilated cardiomyopathy	0.000133	0.00197	CcSEcCtD
Captopril—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000132	0.00195	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.000132	0.00222	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—GPX1—dilated cardiomyopathy	0.000131	0.00221	CbGpPWpGaD
Captopril—ABCB1—heart—dilated cardiomyopathy	0.000131	0.00278	CbGeAlD
Captopril—Shock—Lisinopril—dilated cardiomyopathy	0.00013	0.00192	CcSEcCtD
Captopril—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000129	0.00191	CcSEcCtD
Captopril—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000129	0.0019	CcSEcCtD
Captopril—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000128	0.00215	CbGpPWpGaD
Captopril—F2—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000127	0.00214	CbGpPWpGaD
Captopril—Asthenia—Furosemide—dilated cardiomyopathy	0.000126	0.00186	CcSEcCtD
Captopril—Anorexia—Lisinopril—dilated cardiomyopathy	0.000126	0.00186	CcSEcCtD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000125	0.00211	CbGpPWpGaD
Captopril—Pruritus—Furosemide—dilated cardiomyopathy	0.000124	0.00184	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000124	0.00208	CbGpPWpGaD
Captopril—Hypotension—Lisinopril—dilated cardiomyopathy	0.000123	0.00182	CcSEcCtD
Captopril—MMP9—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.000123	0.00207	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—FAS—dilated cardiomyopathy	0.000123	0.00207	CbGpPWpGaD
Captopril—MMP2—Axon guidance—PSEN2—dilated cardiomyopathy	0.000123	0.00206	CbGpPWpGaD
Captopril—F2—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000122	0.00205	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000121	0.00204	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.000121	0.00204	CbGpPWpGaD
Captopril—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00012	0.00178	CcSEcCtD
Captopril—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00012	0.00178	CcSEcCtD
Captopril—REN—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000119	0.00201	CbGpPWpGaD
Captopril—Insomnia—Lisinopril—dilated cardiomyopathy	0.000119	0.00176	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—RAC1—dilated cardiomyopathy	0.000119	0.002	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000119	0.002	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.000119	0.002	CbGpPWpGaD
Captopril—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000118	0.00175	CcSEcCtD
Captopril—MMP9—Matrix Metalloproteinases—TNF—dilated cardiomyopathy	0.000118	0.00198	CbGpPWpGaD
Captopril—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000117	0.00174	CcSEcCtD
Captopril—Somnolence—Lisinopril—dilated cardiomyopathy	0.000117	0.00173	CcSEcCtD
Captopril—Dizziness—Furosemide—dilated cardiomyopathy	0.000116	0.00172	CcSEcCtD
Captopril—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000116	0.00172	CcSEcCtD
Captopril—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000115	0.0017	CcSEcCtD
Captopril—Fatigue—Lisinopril—dilated cardiomyopathy	0.000114	0.00168	CcSEcCtD
Captopril—Constipation—Lisinopril—dilated cardiomyopathy	0.000113	0.00167	CcSEcCtD
Captopril—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000112	0.00189	CbGpPWpGaD
Captopril—Vomiting—Furosemide—dilated cardiomyopathy	0.000112	0.00165	CcSEcCtD
Captopril—MMP9—amb2 Integrin signaling—TNF—dilated cardiomyopathy	0.000112	0.00188	CbGpPWpGaD
Captopril—Rash—Furosemide—dilated cardiomyopathy	0.000111	0.00164	CcSEcCtD
Captopril—Dermatitis—Furosemide—dilated cardiomyopathy	0.000111	0.00164	CcSEcCtD
Captopril—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000111	0.00186	CbGpPWpGaD
Captopril—Headache—Furosemide—dilated cardiomyopathy	0.00011	0.00163	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.000109	0.00183	CbGpPWpGaD
Captopril—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000109	0.00161	CcSEcCtD
Captopril—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000108	0.00159	CcSEcCtD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000105	0.00177	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000105	0.00177	CbGpPWpGaD
Captopril—Nausea—Furosemide—dilated cardiomyopathy	0.000104	0.00154	CcSEcCtD
Captopril—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000104	0.00154	CcSEcCtD
Captopril—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000104	0.00154	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000104	0.00175	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000103	0.00173	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000103	0.00173	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000101	0.00171	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000101	0.0017	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.0001	0.00169	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.0001	0.00169	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	9.65e-05	0.00162	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	9.58e-05	0.00161	CbGpPWpGaD
Captopril—Asthenia—Lisinopril—dilated cardiomyopathy	9.46e-05	0.0014	CcSEcCtD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	9.43e-05	0.00159	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	9.4e-05	0.00158	CbGpPWpGaD
Captopril—Pruritus—Lisinopril—dilated cardiomyopathy	9.32e-05	0.00138	CcSEcCtD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.29e-05	0.00156	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.12e-05	0.00154	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—RAC1—dilated cardiomyopathy	9.07e-05	0.00153	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	9.04e-05	0.00152	CbGpPWpGaD
Captopril—Diarrhoea—Lisinopril—dilated cardiomyopathy	9.02e-05	0.00133	CcSEcCtD
Captopril—MMP9—TWEAK Signaling Pathway—TNF—dilated cardiomyopathy	8.98e-05	0.00151	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	8.96e-05	0.00151	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—PSEN2—dilated cardiomyopathy	8.75e-05	0.00147	CbGpPWpGaD
Captopril—Dizziness—Lisinopril—dilated cardiomyopathy	8.71e-05	0.00129	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	8.45e-05	0.00142	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	8.45e-05	0.00142	CbGpPWpGaD
Captopril—Vomiting—Lisinopril—dilated cardiomyopathy	8.38e-05	0.00124	CcSEcCtD
Captopril—Rash—Lisinopril—dilated cardiomyopathy	8.31e-05	0.00123	CcSEcCtD
Captopril—Dermatitis—Lisinopril—dilated cardiomyopathy	8.3e-05	0.00123	CcSEcCtD
Captopril—Headache—Lisinopril—dilated cardiomyopathy	8.26e-05	0.00122	CcSEcCtD
Captopril—MMP9—Axon guidance—PSEN2—dilated cardiomyopathy	8.04e-05	0.00135	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	7.87e-05	0.00132	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	7.86e-05	0.00132	CbGpPWpGaD
Captopril—Nausea—Lisinopril—dilated cardiomyopathy	7.83e-05	0.00116	CcSEcCtD
Captopril—MMP2—Axon guidance—ITGB1—dilated cardiomyopathy	7.67e-05	0.00129	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	7.63e-05	0.00128	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—TAZ—dilated cardiomyopathy	7.63e-05	0.00128	CbGpPWpGaD
Captopril—F2—Hemostasis—TTN—dilated cardiomyopathy	7.35e-05	0.00124	CbGpPWpGaD
Captopril—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	6.87e-05	0.00116	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—EGFR—dilated cardiomyopathy	6.73e-05	0.00113	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	6.58e-05	0.00111	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	6.57e-05	0.00111	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.54e-05	0.0011	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—AGT—dilated cardiomyopathy	6.53e-05	0.0011	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	6.5e-05	0.00109	CbGpPWpGaD
Captopril—F2—Hemostasis—ACTN2—dilated cardiomyopathy	6.37e-05	0.00107	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.36e-05	0.00107	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.36e-05	0.00107	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	6.21e-05	0.00105	CbGpPWpGaD
Captopril—MMP2—Axon guidance—RAC1—dilated cardiomyopathy	6.17e-05	0.00104	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	6.03e-05	0.00102	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	5.93e-05	0.000999	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—LMNA—dilated cardiomyopathy	5.93e-05	0.000998	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	5.93e-05	0.000998	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.91e-05	0.000996	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	5.89e-05	0.000991	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	5.81e-05	0.000979	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—PSEN2—dilated cardiomyopathy	5.74e-05	0.000966	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	5.67e-05	0.000954	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	5.67e-05	0.000954	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	5.66e-05	0.000952	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EGFR—dilated cardiomyopathy	5.49e-05	0.000924	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ITGB1—dilated cardiomyopathy	5.47e-05	0.000921	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	5.42e-05	0.000912	CbGpPWpGaD
Captopril—F2—Hemostasis—VCL—dilated cardiomyopathy	5.42e-05	0.000912	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	5.33e-05	0.000897	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	5.27e-05	0.000887	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	5.22e-05	0.000878	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—ACE—dilated cardiomyopathy	5.12e-05	0.000861	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	5.1e-05	0.000859	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	5.05e-05	0.000851	CbGpPWpGaD
Captopril—MMP9—Axon guidance—ITGB1—dilated cardiomyopathy	5.03e-05	0.000847	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	4.9e-05	0.000826	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.86e-05	0.000817	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	4.83e-05	0.000813	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TNF—dilated cardiomyopathy	4.83e-05	0.000813	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	4.82e-05	0.000812	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.72e-05	0.000795	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.72e-05	0.000795	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CD36—dilated cardiomyopathy	4.67e-05	0.000786	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GPX1—dilated cardiomyopathy	4.63e-05	0.00078	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AGT—dilated cardiomyopathy	4.63e-05	0.00078	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	4.57e-05	0.00077	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	4.56e-05	0.000767	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CD36—dilated cardiomyopathy	4.51e-05	0.000759	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	4.5e-05	0.000758	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—RAC1—dilated cardiomyopathy	4.4e-05	0.000741	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.39e-05	0.000739	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	4.36e-05	0.000734	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	4.32e-05	0.000727	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	4.32e-05	0.000727	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	4.24e-05	0.000714	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	4.17e-05	0.000702	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	4.14e-05	0.000697	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	4.13e-05	0.000696	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—EGFR—dilated cardiomyopathy	4.13e-05	0.000695	CbGpPWpGaD
Captopril—MMP2—Axon guidance—RAF1—dilated cardiomyopathy	4.09e-05	0.000688	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AGT—dilated cardiomyopathy	4.06e-05	0.000684	CbGpPWpGaD
Captopril—MMP9—Axon guidance—RAC1—dilated cardiomyopathy	4.04e-05	0.000681	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	4.03e-05	0.000678	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	4.01e-05	0.000676	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.01e-05	0.000676	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TNF—dilated cardiomyopathy	3.93e-05	0.000661	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	3.89e-05	0.000654	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	3.85e-05	0.000649	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.84e-05	0.000646	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	3.83e-05	0.000646	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	3.83e-05	0.000645	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	3.82e-05	0.000643	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.72e-05	0.000627	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ITGB1—dilated cardiomyopathy	3.59e-05	0.000604	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	3.58e-05	0.000602	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	3.55e-05	0.000598	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.5e-05	0.00059	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.42e-05	0.000577	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	3.32e-05	0.000559	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—AGT—dilated cardiomyopathy	3.24e-05	0.000546	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.15e-05	0.00053	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.07e-05	0.000516	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CD36—dilated cardiomyopathy	3.06e-05	0.000516	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—LMNA—dilated cardiomyopathy	3e-05	0.000505	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—RAF1—dilated cardiomyopathy	2.92e-05	0.000491	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	2.92e-05	0.000491	CbGpPWpGaD
Captopril—ALB—Hemostasis—TTN—dilated cardiomyopathy	2.92e-05	0.000491	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—RAC1—dilated cardiomyopathy	2.89e-05	0.000486	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	2.87e-05	0.000484	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	2.81e-05	0.000473	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—dilated cardiomyopathy	2.8e-05	0.000472	CbGpPWpGaD
Captopril—F2—Hemostasis—ITGB1—dilated cardiomyopathy	2.72e-05	0.000458	CbGpPWpGaD
Captopril—MMP9—Axon guidance—RAF1—dilated cardiomyopathy	2.68e-05	0.000451	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	2.64e-05	0.000445	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ACE—dilated cardiomyopathy	2.59e-05	0.000436	CbGpPWpGaD
Captopril—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	2.53e-05	0.000426	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.52e-05	0.000425	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.45e-05	0.000413	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.45e-05	0.000413	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.44e-05	0.000411	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.44e-05	0.000411	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	2.35e-05	0.000396	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.34e-05	0.000393	CbGpPWpGaD
Captopril—F2—Hemostasis—CD36—dilated cardiomyopathy	2.32e-05	0.00039	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.28e-05	0.000384	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.27e-05	0.000382	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.22e-05	0.000373	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.22e-05	0.000373	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.21e-05	0.000372	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.2e-05	0.00037	CbGpPWpGaD
Captopril—F2—Hemostasis—RAC1—dilated cardiomyopathy	2.19e-05	0.000368	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.15e-05	0.000362	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.15e-05	0.000362	CbGpPWpGaD
Captopril—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.15e-05	0.000362	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.06e-05	0.000347	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—dilated cardiomyopathy	2e-05	0.000337	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2e-05	0.000337	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.99e-05	0.000336	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	1.97e-05	0.000332	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	1.92e-05	0.000323	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—RAF1—dilated cardiomyopathy	1.91e-05	0.000322	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.91e-05	0.000321	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—dilated cardiomyopathy	1.91e-05	0.000321	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.88e-05	0.000316	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—dilated cardiomyopathy	1.84e-05	0.00031	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	1.79e-05	0.000301	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.78e-05	0.0003	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.75e-05	0.000295	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.7e-05	0.000287	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.69e-05	0.000285	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.69e-05	0.000285	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.69e-05	0.000284	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	1.68e-05	0.000283	CbGpPWpGaD
Captopril—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	1.66e-05	0.000279	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.66e-05	0.000279	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—AGT—dilated cardiomyopathy	1.64e-05	0.000277	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.62e-05	0.000272	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.58e-05	0.000265	CbGpPWpGaD
Captopril—ALB—Metabolism—TAZ—dilated cardiomyopathy	1.56e-05	0.000263	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.53e-05	0.000257	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.52e-05	0.000256	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.47e-05	0.000248	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.45e-05	0.000245	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.45e-05	0.000245	CbGpPWpGaD
Captopril—F2—Hemostasis—RAF1—dilated cardiomyopathy	1.45e-05	0.000244	CbGpPWpGaD
Captopril—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.41e-05	0.000237	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.38e-05	0.000233	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.37e-05	0.000231	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.37e-05	0.00023	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.32e-05	0.000222	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—dilated cardiomyopathy	1.31e-05	0.000221	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.31e-05	0.00022	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.31e-05	0.00022	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.3e-05	0.000219	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.29e-05	0.000217	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.29e-05	0.000217	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.25e-05	0.000211	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—dilated cardiomyopathy	1.25e-05	0.00021	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.24e-05	0.000208	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.24e-05	0.000208	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.22e-05	0.000205	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.2e-05	0.000202	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.18e-05	0.000198	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.16e-05	0.000196	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.12e-05	0.000188	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.1e-05	0.000185	CbGpPWpGaD
Captopril—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.08e-05	0.000182	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.06e-05	0.000179	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.01e-05	0.000169	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAC1—dilated cardiomyopathy	9.6e-06	0.000162	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.58e-06	0.000161	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.55e-06	0.000161	CbGpPWpGaD
Captopril—ALB—Hemostasis—CD36—dilated cardiomyopathy	9.2e-06	0.000155	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGT—dilated cardiomyopathy	9.17e-06	0.000154	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAC1—dilated cardiomyopathy	8.67e-06	0.000146	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.6e-06	0.000145	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.38e-06	0.000141	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.32e-06	0.00014	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.2e-06	0.000138	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.54e-06	0.000127	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.53e-06	0.000127	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.41e-06	0.000125	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.17e-06	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGT—dilated cardiomyopathy	7.08e-06	0.000119	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAF1—dilated cardiomyopathy	6.36e-06	0.000107	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAF1—dilated cardiomyopathy	5.75e-06	9.68e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.7e-06	9.6e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.98e-06	8.38e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.91e-06	8.27e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—dilated cardiomyopathy	4.36e-06	7.35e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.36e-06	7.34e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—dilated cardiomyopathy	3.83e-06	6.45e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CD36—dilated cardiomyopathy	3.73e-06	6.28e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.37e-06	5.67e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AGT—dilated cardiomyopathy	3.36e-06	5.66e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.36e-06	5.65e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.27e-06	5.5e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.16e-06	5.33e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.08e-06	5.19e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.94e-06	4.96e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.77e-06	4.67e-05	CbGpPWpGaD
